Home » Novasight Hybrid System Receives FDA Clearance
Novasight Hybrid System Receives FDA Clearance
Devices Submissions and Approvals
Conavi Medical’s coronary artery imaging system received 510(k) clearance from the FDA for use in imaging coronary anatomy during angioplasty and stenting procedures.
The device enables simultaneous imaging of coronary arteries using both intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
It can acquire both IVUS and OCT images using a single catheter, combining the resolution and contrast of OCT with IVUS’ larger field of view.